Cronos Group Inc (CRON)
2.06
-0.01
(-0.48%)
USD |
NASDAQ |
Nov 15, 11:55
Cronos Group Profit Margin (Quarterly): -31.54% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -31.54% |
March 31, 2024 | -8.86% |
December 31, 2023 | -187.3% |
September 30, 2023 | -6.63% |
June 30, 2023 | -43.95% |
March 31, 2023 | -98.33% |
December 31, 2022 | -358.0% |
September 30, 2022 | -181.2% |
June 30, 2022 | -93.61% |
March 31, 2022 | -130.4% |
December 31, 2021 | -839.4% |
September 30, 2021 | |
June 30, 2021 | -1.15K% |
March 31, 2021 | -1.28K% |
December 31, 2020 | -652.5% |
September 30, 2020 |
Date | Value |
---|---|
June 30, 2020 | -1.08K% |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | -367.1% |
September 30, 2018 | -191.8% |
June 30, 2018 | 21.30% |
March 31, 2018 | -35.65% |
December 31, 2017 | -158.3% |
September 30, 2017 | 83.49% |
June 30, 2017 | 27.06% |
March 31, 2017 | -164.2% |
December 31, 2016 | |
September 30, 2016 | -184.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.28K%
Minimum
Mar 2021
-6.63%
Maximum
Sep 2023
-409.3%
Average
-181.2%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
Tilray Brands Inc | -19.58% |
Aurinia Pharmaceuticals Inc | 21.17% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -2.12K% |
Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -5.24% |
Return on Assets | -5.08% |
Return on Invested Capital | -5.24% |
Gross Profit Margin (Quarterly) | 22.68% |
Operating Margin (Quarterly) | -54.08% |
Return on Net Operating Assets | -40.48% |